PV/Drug Safety Solutions for Pharma
Assyro AI empowers pharmacovigilance professionals in pharmaceutical companies with intelligent regulatory tools. Assyro AI supports pharmacovigilance professionals with regulatory intelligence on safety reporting requirements, signal detection, and risk management. Stay compliant with global PV obligations and evolving safety standards.
What PV/Drug Safety Teams Do
- Managing adverse event reporting and safety databases
- Preparing periodic safety reports (PSUR/PBRER)
- Conducting signal detection and safety surveillance
- Developing and maintaining risk management plans
- Ensuring compliance with global PV regulations
Challenges in Pharma
- Managing increasing volume of safety data and reports
- Tracking country-specific reporting requirements and timelines
- Keeping up with evolving pharmacovigilance regulations
- Cross-functional teams misalign on Module 2 summaries weeks before submission lock
- Manual eCTD assembly creates structural defects caught too late to fix cleanly
How Assyro AI Helps
- Track global pharmacovigilance regulations and requirements
- Monitor FDA and EMA safety-related announcements
- Generate safety documentation with AI assistance
- Cut NDA and sNDA prep time by 60% with AI-assisted drafting and automated readiness checks
- Validate eCTD sequences in real time against FDA technical specs before gateway dispatch
Key Skills We Support
- Adverse event assessment
- Signal detection
- Safety reporting
- Risk management
- Regulatory compliance
Regulations We Cover
- 21 CFR Part 11
- ICH CTD/eCTD
- FDA guidance
- EMA guidelines
- GxP
Frequently Asked Questions
Assyro AI provides PV teams with regulatory intelligence on global safety reporting requirements, signal detection guidance, and risk management frameworks. Our AI helps track changing PV regulations across markets.
Regulatory Context
PV/Drug Safety teams in Pharma depend on current regulatory intelligence to keep submissions, quality narratives, and inspection responses aligned with health-authority expectations.
Common Mistakes
- Running signal reviews on fixed schedules without event-triggered checks.
- Weak integration between safety findings and label/risk communication updates.
- Limited visibility into enforcement trends that predict agency scrutiny.
Key Regulatory Terms
- Signal Detection
Signal detection is the pharmacovigilance activity of searching safety data for evidence that a medicine may cause a new adverse reaction, or that a known reaction has changed, before that evidence is confirmed.
- PSUR
Periodic Safety Update Report is a pharmacovigilance document a marketing authorisation holder submits at fixed intervals to re-evaluate an authorised medicine's benefit-risk balance against the safety data accumulated worldwide since the previous report.
Relevant Regulatory Intelligence
Related Actions
Other Roles in Pharma
PV/Drug Safety in Other Industries
Ready to Transform Your PV/Drug Safety Operations?
See how Assyro AI can accelerate regulatory work for pharmacovigilance professionals in pharmaceutical companies.
Schedule a Demo